Literature DB >> 11895451

A proposal to redefine familial combined hyperlipidaemia -- third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European Society for Clinical Investigation.

A D Sniderman1, M Castro Cabezas, J Ribalta, R Carmena, T W A de Bruin, J de Graaf, D W Erkelens, S E Humphries, L Masana, J T Real, P J Talmud, M R Taskinen.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11895451     DOI： 10.1046/j.1365-2362.2002.00941.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN： 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  5 in total

Review 1.  Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids.

Authors:  Jacqueline de Graaf; Mario J Veerkamp; Anton F H Stalenhoef
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 2.  Pathophysiology of dyslipidaemia in the metabolic syndrome.

Authors:  G D Kolovou; K K Anagnostopoulou; D V Cokkinos
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

3.  Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate.

Authors:  Arrigo F G Cicero; Giuseppe Derosa; Pamela Maffioli; Alessandra Reggi; Elisa Grandi; Claudio Borghi
Journal:  Arch Med Sci       Date:  2013-04-09       Impact factor: 3.318

Review 4.  Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date.

Authors:  Antonio Gaddi; A F G Cicero; F O Odoo; A A Poli; R Paoletti
Journal:  Vasc Health Risk Manag       Date:  2007

5.  Incidence of type 2 diabetes in familial combined hyperlipidemia.

Authors:  Martijn C G J Brouwers; Jacqueline de Graaf; Nynke Simons; Steven Meex; Sophie Ten Doeschate; Shadana van Heertum; Britt Heidemann; Jim Luijten; Douwe de Boer; Nicolaas Schaper; Coen D A Stehouwer; Marleen M J van Greevenbroek
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.